JGC
J. Goldman & Co’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.8M | Buy |
33,846
+18,960
| +127% | +$9.95M | 0.43% | 57 |
|
|
2025
Q1 | $9.44M | Buy |
14,886
+2,298
| +18% | +$1.46M | 0.23% | 98 |
|
|
2024
Q4 | $8.97M | Buy |
12,588
+3,694
| +42% | +$2.63M | 0.23% | 103 |
|
|
2024
Q3 | $9.35M | Buy |
8,894
+3,208
| +56% | +$3.37M | 0.26% | 78 |
|
|
2024
Q2 | $5.98M | Sell |
5,686
-912
| -14% | -$959K | 0.17% | 113 |
|
|
2024
Q1 | $6.35M | Sell |
6,598
-39,005
| -86% | -$37.5M | 0.2% | 95 |
|
|
2023
Q4 | $40.1M | Sell |
45,603
-17
| -0% | -$14.9K | 1.62% | 7 |
|
|
2023
Q3 | $37.5M | Buy |
45,620
+25,814
| +130% | +$21.2M | 1.32% | 9 |
|
|
2023
Q2 | $14.2M | Buy |
19,806
+17,759
| +868% | +$12.8M | 0.52% | 43 |
|
|
2023
Q1 | $1.68M | Sell |
2,047
-19,854
| -91% | -$16.3M | 0.07% | 152 |
|
|
2022
Q4 | $15.8M | Buy |
21,901
+17,867
| +443% | +$12.9M | 0.78% | 24 |
|
|
2022
Q3 | $2.78M | Sell |
4,034
-825
| -17% | -$568K | 0.13% | 123 |
|
|
2022
Q2 | $2.87M | Buy |
+4,859
| New | +$2.87M | 0.14% | 115 |
|